Study to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriatic Subject
Clinical trial NCT02303509 · COMPLETED
Trial details
- NCT number
- NCT02303509
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2014-02-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.